On Oct. 31 the Fédération Equestre Internationale (FEI) announced two adverse analytical findings involving two equine prohibited substances.

The cases involve banned substances under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs). The athletes have been provisionally suspended from the date of notification until the FEI Tribunal renders its decisions. The horses have been provisionally suspended for two months:

Horse: Caipirina
Person Responsible: Juan Pablo Garcia Salgado (COL)
Event: CIC1* at Bonza (COL), Sept. 20-22, 2018
Prohibited substances: Boldenone and boldenone undecylenate (both anabolic-androgenic steroids) and ractopamine (a beta adrenoceptor agonist which, according to the FEI Equine Prohibited Substance Database, has been shown to improve growth in pigs; it is not approved for use in equids)
Date of notification: Oct. 30, 2018

Horse: Bardolina 2
Person Responsible: Mario Deslauriers (CAN)
Event: CSIO5* Nations Cup Final at Barcelona (ESP), Oct. 05-07, 2018
Prohibited Substance: O-desmethylvenlafaxine (a metabolite of venlafaxine; an antidepressant agent, categorized as a serotonin and noradrenaline re-uptake inhibitor; in humans it is used to treat major depression and generalized anxiety disorders, according to the FEI Equine Prohibited Substance Database)
Date of notification: Oct